Header Logo

Alan Go

Concepts (919)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Renal Insufficiency, Chronic
107
2023
179
19.260
Why?
Atrial Fibrillation
109
2024
170
19.220
Why?
Stroke
94
2024
311
12.940
Why?
Heart Failure
70
2024
396
12.610
Why?
Kidney Failure, Chronic
51
2023
147
9.610
Why?
Anticoagulants
67
2024
127
8.650
Why?
Aged
298
2024
6095
7.850
Why?
Myocardial Infarction
54
2022
238
7.820
Why?
Acute Kidney Injury
28
2024
43
7.740
Why?
Humans
471
2024
17611
7.620
Why?
Male
329
2024
10008
6.900
Why?
Female
341
2024
12608
6.500
Why?
Cardiovascular Diseases
54
2023
598
6.420
Why?
Warfarin
39
2023
74
6.270
Why?
Middle Aged
263
2024
7911
6.080
Why?
Risk Factors
181
2023
3325
5.960
Why?
Glomerular Filtration Rate
62
2023
153
5.340
Why?
Aged, 80 and over
111
2024
1900
5.330
Why?
Coronary Artery Disease
28
2022
134
5.240
Why?
Hospitalization
51
2024
797
5.240
Why?
Risk Assessment
71
2023
1097
4.980
Why?
Coronary Disease
22
2019
181
4.230
Why?
Coronary Artery Bypass
11
2016
26
3.940
Why?
Venous Thromboembolism
10
2023
52
3.930
Why?
Cohort Studies
103
2023
2570
3.800
Why?
Retrospective Studies
84
2023
2447
3.760
Why?
Adult
142
2024
7598
3.620
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
15
2022
171
3.590
Why?
Heart Diseases
24
2019
77
3.580
Why?
Kidney
16
2022
52
3.550
Why?
Registries
41
2022
471
3.510
Why?
Treatment Outcome
59
2022
1259
3.320
Why?
United States
129
2024
3956
3.270
Why?
American Heart Association
22
2022
49
3.240
Why?
California
68
2024
2284
3.210
Why?
Percutaneous Coronary Intervention
10
2016
22
3.190
Why?
Incidence
67
2023
1255
3.160
Why?
Ventricular Function, Left
19
2024
51
3.100
Why?
Hypertension
18
2023
500
3.040
Why?
Disease Progression
37
2024
264
3.000
Why?
Atherosclerosis
12
2023
51
2.670
Why?
Time Factors
52
2024
1086
2.600
Why?
Adrenergic beta-Antagonists
12
2017
43
2.550
Why?
Follow-Up Studies
64
2021
1210
2.460
Why?
Angiotensin-Converting Enzyme Inhibitors
8
2022
86
2.440
Why?
Thromboembolism
15
2023
32
2.410
Why?
Prognosis
52
2023
606
2.400
Why?
Prospective Studies
77
2024
1267
2.380
Why?
Renal Dialysis
18
2020
54
2.360
Why?
Creatinine
20
2023
65
2.330
Why?
Stroke Volume
16
2024
100
2.190
Why?
Proteinuria
11
2021
26
2.180
Why?
Angiotensin Receptor Antagonists
4
2022
53
2.090
Why?
Delivery of Health Care, Integrated
11
2023
531
2.080
Why?
Emergency Service, Hospital
11
2024
358
2.040
Why?
Biomarkers
40
2024
301
1.990
Why?
Hemorrhage
26
2023
62
1.990
Why?
Kidney Diseases
11
2011
53
1.970
Why?
Primary Prevention
9
2018
73
1.940
Why?
Patient Discharge
11
2024
154
1.880
Why?
Defibrillators, Implantable
8
2018
32
1.860
Why?
Proportional Hazards Models
39
2021
709
1.820
Why?
Biomedical Research
9
2024
86
1.820
Why?
Cause of Death
20
2021
181
1.780
Why?
Continental Population Groups
13
2021
302
1.680
Why?
Platelet Aggregation Inhibitors
9
2021
24
1.670
Why?
Patient Readmission
9
2020
163
1.660
Why?
Death, Sudden, Cardiac
8
2018
35
1.610
Why?
Comorbidity
32
2023
594
1.590
Why?
Brain Ischemia
13
2016
37
1.590
Why?
Cardiology
7
2022
30
1.560
Why?
Hyperkalemia
2
2022
16
1.540
Why?
Age Factors
35
2024
917
1.520
Why?
Blood Pressure
18
2023
298
1.490
Why?
Ventricular Dysfunction, Left
8
2017
20
1.450
Why?
Severity of Illness Index
19
2020
454
1.440
Why?
Research Report
7
2020
22
1.400
Why?
Renin-Angiotensin System
2
2020
17
1.400
Why?
Mortality
13
2021
117
1.390
Why?
Pulmonary Embolism
4
2020
44
1.340
Why?
Anti-Arrhythmia Agents
4
2019
12
1.320
Why?
Cystatin C
7
2023
15
1.300
Why?
National Heart, Lung, and Blood Institute (U.S.)
8
2023
19
1.300
Why?
Outpatients
4
2023
107
1.290
Why?
Polymorphism, Single Nucleotide
18
2015
373
1.270
Why?
Anemia
8
2020
32
1.220
Why?
Prevalence
36
2018
884
1.200
Why?
Natural Language Processing
3
2024
57
1.190
Why?
Diabetes Mellitus
11
2019
487
1.170
Why?
Morbidity
5
2020
59
1.160
Why?
Atrial Flutter
7
2023
15
1.160
Why?
Young Adult
37
2020
2427
1.150
Why?
Fibrinolytic Agents
14
2016
44
1.140
Why?
International Normalized Ratio
14
2022
22
1.130
Why?
Catheter Ablation
4
2019
11
1.130
Why?
Survival Rate
24
2019
260
1.110
Why?
Electric Countershock
7
2017
16
1.100
Why?
Cross-Sectional Studies
41
2022
1322
1.080
Why?
Troponin I
3
2016
8
1.080
Why?
Predictive Value of Tests
24
2020
351
1.070
Why?
Multivariate Analysis
23
2019
568
1.050
Why?
Digoxin
3
2015
12
1.050
Why?
Algorithms
8
2021
233
1.050
Why?
Vitamin K
10
2022
15
1.000
Why?
Angioplasty, Balloon, Coronary
3
2014
10
1.000
Why?
Multiple Chronic Conditions
2
2023
25
0.990
Why?
Odds Ratio
20
2016
671
0.980
Why?
Venous Thrombosis
3
2020
21
0.980
Why?
Medication Adherence
3
2020
244
0.960
Why?
Cardiomyopathies
3
2015
10
0.950
Why?
Chronic Disease
14
2023
428
0.950
Why?
Outcome Assessment (Health Care)
9
2018
228
0.940
Why?
Potassium
2
2022
16
0.940
Why?
Cognition Disorders
6
2017
31
0.930
Why?
Hispanic Americans
12
2016
404
0.930
Why?
Drug-Eluting Stents
4
2014
8
0.920
Why?
Ticlopidine
9
2016
16
0.900
Why?
Heart Failure, Systolic
2
2013
4
0.900
Why?
Disease Management
6
2020
135
0.900
Why?
Peripheral Arterial Disease
6
2021
13
0.900
Why?
Secondary Prevention
3
2020
47
0.880
Why?
Dabigatran
6
2018
8
0.870
Why?
Hemoglobins
6
2020
39
0.860
Why?
Adolescent
25
2022
3651
0.850
Why?
Transcatheter Aortic Valve Replacement
1
2022
2
0.850
Why?
Aortic Valve Stenosis
1
2022
3
0.850
Why?
Clinical Trials as Topic
10
2016
130
0.850
Why?
European Continental Ancestry Group
16
2017
529
0.850
Why?
Office Visits
2
2020
80
0.820
Why?
African Americans
12
2022
472
0.810
Why?
Quality of Life
15
2024
507
0.810
Why?
Forecasting
2
2021
75
0.810
Why?
Pregnancy Complications, Cardiovascular
2
2013
27
0.810
Why?
Survival Analysis
12
2019
215
0.810
Why?
Telephone
2
2020
161
0.800
Why?
Fibroblast Growth Factors
6
2019
11
0.790
Why?
Glomerulosclerosis, Focal Segmental
1
2021
1
0.790
Why?
Glomerulonephritis, Membranous
1
2021
1
0.790
Why?
Nephrotic Syndrome
1
2021
5
0.790
Why?
Chi-Square Distribution
14
2015
154
0.780
Why?
Dementia
2
2023
106
0.770
Why?
Hypertrophy, Left Ventricular
9
2017
13
0.770
Why?
Propensity Score
7
2019
85
0.770
Why?
Sex Factors
18
2024
643
0.760
Why?
Medicare
8
2022
202
0.760
Why?
Education
2
2020
17
0.750
Why?
Drug Monitoring
2
2020
20
0.750
Why?
Eicosapentaenoic Acid
1
2021
9
0.750
Why?
Aftercare
2
2020
49
0.750
Why?
Arrhythmias, Cardiac
2
2018
32
0.730
Why?
Genome-Wide Association Study
9
2023
243
0.730
Why?
Kaplan-Meier Estimate
11
2019
129
0.730
Why?
Mobility Limitation
1
2020
16
0.730
Why?
Independent Living
1
2020
21
0.720
Why?
Angina Pectoris
4
2007
16
0.710
Why?
Electrocardiography
15
2024
42
0.710
Why?
Myocardial Revascularization
5
2019
12
0.710
Why?
Troponin T
8
2022
10
0.710
Why?
Logistic Models
20
2016
926
0.710
Why?
Case-Control Studies
20
2016
1115
0.710
Why?
Aspirin
11
2016
63
0.710
Why?
Dopamine Agonists
1
2020
3
0.700
Why?
Neoplasms
7
2019
438
0.700
Why?
Heart Rate
6
2015
40
0.700
Why?
Hyperprolactinemia
1
2020
3
0.700
Why?
Data Accuracy
1
2020
27
0.700
Why?
Inpatients
3
2017
81
0.700
Why?
Heart Valve Diseases
1
2020
20
0.700
Why?
Intracranial Hemorrhages
7
2012
16
0.690
Why?
Aging
4
2019
161
0.690
Why?
Longitudinal Studies
15
2021
710
0.690
Why?
Databases, Factual
7
2019
309
0.680
Why?
Practice Patterns, Physicians'
7
2017
330
0.680
Why?
Renal Insufficiency
2
2023
13
0.680
Why?
Electronic Health Records
6
2024
681
0.670
Why?
Inflammation
5
2024
62
0.670
Why?
Coronavirus Infections
1
2020
49
0.660
Why?
Pneumonia, Viral
1
2020
56
0.660
Why?
Cardiovascular Agents
3
2020
24
0.650
Why?
Research Design
8
2012
374
0.650
Why?
Lung Diseases
2
2017
42
0.640
Why?
Pandemics
2
2022
287
0.640
Why?
Antithrombins
2
2017
4
0.630
Why?
Patient Selection
11
2014
190
0.620
Why?
Kidney Transplantation
4
2014
29
0.620
Why?
Sex Characteristics
4
2015
69
0.610
Why?
Body Mass Index
9
2015
958
0.600
Why?
Patient Acceptance of Health Care
2
2021
382
0.590
Why?
Postoperative Hemorrhage
2
2015
8
0.590
Why?
Kidney Function Tests
8
2022
22
0.590
Why?
Quality Indicators, Health Care
3
2017
181
0.590
Why?
Non-ST Elevated Myocardial Infarction
2
2016
8
0.580
Why?
Obesity
6
2015
837
0.580
Why?
Genetic Predisposition to Disease
10
2015
368
0.580
Why?
Population Surveillance
5
2013
263
0.560
Why?
Age Distribution
11
2019
246
0.560
Why?
Cardiotonic Agents
2
2013
12
0.560
Why?
Electrocardiography, Ambulatory
2
2016
2
0.550
Why?
Diabetic Cardiomyopathies
1
2016
4
0.550
Why?
ST Elevation Myocardial Infarction
1
2016
5
0.550
Why?
Factor Xa Inhibitors
4
2020
10
0.540
Why?
Data Collection
7
2020
256
0.530
Why?
Bradycardia
1
2016
1
0.530
Why?
Sinus Arrest, Cardiac
1
2016
1
0.530
Why?
Atrioventricular Block
1
2016
1
0.530
Why?
Tachycardia, Ventricular
1
2016
6
0.530
Why?
Surveys and Questionnaires
12
2020
1309
0.530
Why?
African Continental Ancestry Group
7
2021
162
0.530
Why?
Peptide Fragments
6
2022
27
0.520
Why?
Health Maintenance Organizations
11
2017
417
0.520
Why?
Natriuretic Peptide, Brain
6
2022
27
0.520
Why?
Overweight
3
2010
269
0.510
Why?
Evidence-Based Medicine
6
2016
185
0.510
Why?
Calcinosis
7
2012
40
0.500
Why?
Clinical Laboratory Techniques
1
2015
10
0.490
Why?
Stents
1
2014
11
0.490
Why?
Diphosphonates
3
2011
62
0.490
Why?
Vascular Calcification
3
2022
9
0.480
Why?
Heart Function Tests
1
2014
3
0.470
Why?
Primary Health Care
1
2020
766
0.470
Why?
Delivery of Health Care
3
2020
415
0.470
Why?
Administration, Oral
13
2022
85
0.460
Why?
Spironolactone
1
2013
6
0.450
Why?
Practice Guidelines as Topic
5
2017
318
0.440
Why?
Birth Rate
1
2013
5
0.440
Why?
Randomized Controlled Trials as Topic
8
2023
322
0.430
Why?
Coronary Vessels
5
2022
15
0.430
Why?
Recovery of Function
4
2020
27
0.430
Why?
Multimorbidity
2
2023
14
0.420
Why?
Child, Preschool
8
2021
1409
0.420
Why?
Sex Distribution
10
2019
190
0.420
Why?
Ethnic Groups
7
2021
485
0.420
Why?
Likelihood Functions
1
2012
44
0.420
Why?
Monitoring, Ambulatory
1
2012
18
0.410
Why?
Interleukin-6
4
2022
25
0.410
Why?
Quality Improvement
2
2013
189
0.410
Why?
Infant
5
2023
1171
0.410
Why?
Diabetic Retinopathy
3
2020
18
0.410
Why?
Acute Disease
5
2019
142
0.410
Why?
Asian Americans
5
2011
176
0.400
Why?
Cholesterol, LDL
5
2016
119
0.400
Why?
Motor Activity
6
2013
212
0.400
Why?
Sensitivity and Specificity
12
2015
304
0.400
Why?
Angina, Stable
1
2011
4
0.390
Why?
Blood Pressure Determination
6
2023
54
0.390
Why?
Recurrence
4
2020
186
0.390
Why?
Heart Ventricles
4
2017
17
0.390
Why?
Puerperal Disorders
1
2011
9
0.390
Why?
Coronary Restenosis
1
2011
1
0.390
Why?
Mouth Diseases
1
2011
3
0.380
Why?
Antihypertensive Agents
4
2016
161
0.380
Why?
Outcome and Process Assessment (Health Care)
6
2017
102
0.370
Why?
Oral Health
1
2011
21
0.370
Why?
Drug Therapy, Combination
7
2019
114
0.370
Why?
Heart
3
2023
13
0.370
Why?
Vascular Diseases
1
2010
4
0.370
Why?
Erythropoietin
3
2007
3
0.370
Why?
Community Health Services
2
2008
83
0.360
Why?
Risk
11
2016
516
0.360
Why?
Asian Continental Ancestry Group
4
2012
90
0.360
Why?
Blood Coagulation Factors
3
2022
10
0.360
Why?
Patient Compliance
3
2020
298
0.360
Why?
Osteoporosis
1
2011
74
0.360
Why?
Child
8
2021
2474
0.360
Why?
Cognition
2
2024
81
0.350
Why?
Quality of Health Care
6
2013
326
0.350
Why?
Graft Rejection
1
2009
5
0.340
Why?
Health Literacy
2
2022
39
0.340
Why?
Guideline Adherence
3
2017
155
0.340
Why?
Mental Disorders
4
2015
280
0.330
Why?
Confidence Intervals
7
2014
237
0.330
Why?
Nocturia
1
2009
4
0.330
Why?
Uric Acid
1
2009
9
0.330
Why?
Reproducibility of Results
14
2021
381
0.330
Why?
Diuretics
2
2022
17
0.320
Why?
Data Interpretation, Statistical
5
2016
77
0.320
Why?
Information Services
1
2008
16
0.320
Why?
Metabolic Syndrome
5
2015
80
0.310
Why?
Hospital Mortality
6
2009
145
0.310
Why?
Communicable Diseases
1
2008
15
0.310
Why?
Decision Support Techniques
4
2020
88
0.310
Why?
Oligosaccharides
1
2008
2
0.310
Why?
C-Reactive Protein
5
2017
58
0.300
Why?
Decision Support Systems, Clinical
3
2024
53
0.300
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2007
4
0.300
Why?
Carbazoles
1
2007
2
0.290
Why?
Tartrates
1
2007
2
0.290
Why?
Propanolamines
1
2007
3
0.290
Why?
Metoprolol
1
2007
6
0.290
Why?
Sepsis
2
2023
70
0.290
Why?
Atenolol
1
2007
8
0.290
Why?
Bundle-Branch Block
4
2000
5
0.290
Why?
Adiposity
2
2015
66
0.290
Why?
Anti-Asthmatic Agents
3
2007
85
0.290
Why?
Vascular Surgical Procedures
3
2015
4
0.290
Why?
Hematinics
1
2007
3
0.290
Why?
Cardiac Resynchronization Therapy
3
2017
4
0.290
Why?
Membrane Proteins
2
2022
38
0.280
Why?
Renal Replacement Therapy
2
2023
9
0.280
Why?
Abdomen
1
2006
20
0.280
Why?
Heart Conduction System
2
2018
4
0.270
Why?
Genotype
9
2022
227
0.270
Why?
Growth Differentiation Factor 15
3
2022
4
0.270
Why?
Vascular Stiffness
2
2017
4
0.260
Why?
Thrombophilia
2
2015
3
0.260
Why?
Dyslipidemias
3
2015
62
0.260
Why?
Polycystic Ovary Syndrome
1
2006
19
0.260
Why?
Quantitative Trait Loci
3
2015
36
0.260
Why?
Process Assessment (Health Care)
2
2017
24
0.260
Why?
Coronary Angiography
3
2014
21
0.260
Why?
Echocardiography
5
2023
32
0.260
Why?
Albuminuria
3
2021
38
0.260
Why?
Lower Extremity
2
2015
12
0.250
Why?
Life Style
3
2022
332
0.250
Why?
Hypolipidemic Agents
2
2020
40
0.250
Why?
Embolism
3
2015
6
0.250
Why?
Comparative Effectiveness Research
3
2015
66
0.250
Why?
Thrombolytic Therapy
4
2001
20
0.250
Why?
Systole
5
2016
22
0.250
Why?
Telemedicine
2
2020
182
0.250
Why?
Health Behavior
4
2016
359
0.250
Why?
Diabetes Mellitus, Type 2
4
2024
748
0.250
Why?
Research
4
2017
64
0.250
Why?
Health Status Indicators
4
2020
64
0.240
Why?
Poverty
2
2024
166
0.240
Why?
Cerebral Hemorrhage
3
2014
14
0.240
Why?
Asthma
3
2007
385
0.240
Why?
Postoperative Complications
3
2016
102
0.240
Why?
Insulin
4
2015
205
0.240
Why?
Echocardiography, Transesophageal
1
2004
3
0.230
Why?
Blood Glucose
4
2016
341
0.230
Why?
Patient Care Management
1
2004
30
0.230
Why?
Analysis of Variance
5
2017
159
0.230
Why?
Specialization
3
2001
24
0.230
Why?
Lung
2
2018
62
0.230
Why?
Medicine
3
2001
22
0.230
Why?
Interleukin-1 Receptor-Like 1 Protein
2
2022
3
0.220
Why?
Health Knowledge, Attitudes, Practice
3
2017
375
0.220
Why?
Cholesterol, HDL
4
2023
79
0.220
Why?
Thiophenes
2
2013
2
0.220
Why?
Factor Xa
2
2013
2
0.220
Why?
Morpholines
2
2013
3
0.220
Why?
Thrombosis
1
2023
11
0.220
Why?
Genetic Variation
3
2014
77
0.220
Why?
Acute Coronary Syndrome
2
2016
18
0.220
Why?
Protective Factors
2
2020
32
0.220
Why?
Models, Statistical
4
2012
177
0.220
Why?
Academies and Institutes
1
2023
7
0.220
Why?
Factor V
1
2003
5
0.220
Why?
Aortic Valve
1
2022
4
0.210
Why?
Aortic Aneurysm, Thoracic
1
2022
1
0.210
Why?
Pre-Eclampsia
1
2023
40
0.210
Why?
Serine Endopeptidases
1
2022
5
0.210
Why?
Prosthesis Implantation
3
2015
6
0.210
Why?
Hypertension, Pregnancy-Induced
1
2023
42
0.210
Why?
Factor IX
1
2022
3
0.210
Why?
Lipocalin-2
3
2017
3
0.210
Why?
Triglycerides
2
2021
86
0.210
Why?
Terminology as Topic
3
2010
17
0.210
Why?
Meals
1
2022
7
0.210
Why?
Retinal Vessels
2
2020
4
0.210
Why?
Lipids
3
2019
77
0.210
Why?
Observational Studies as Topic
2
2020
47
0.200
Why?
Dietary Approaches To Stop Hypertension
1
2022
4
0.200
Why?
Health Status
5
2018
298
0.200
Why?
Emergency Medical Services
2
2021
46
0.200
Why?
Sodium Chloride Symporter Inhibitors
1
2022
9
0.200
Why?
Nephrosis, Lipoid
1
2021
1
0.200
Why?
Mentoring
1
2022
26
0.200
Why?
Churg-Strauss Syndrome
3
2007
5
0.200
Why?
Antiviral Agents
1
2022
94
0.200
Why?
Angioedema
1
2021
6
0.200
Why?
Risk Reduction Behavior
2
2020
108
0.200
Why?
Biopsy
1
2021
74
0.190
Why?
Calcium
3
2012
34
0.190
Why?
Animals
5
2021
259
0.190
Why?
Health Services Accessibility
2
2020
289
0.190
Why?
Fibrinogen
3
2017
13
0.190
Why?
Chitinase-3-Like Protein 1
1
2021
1
0.190
Why?
Chemokine CCL2
1
2021
1
0.190
Why?
Kidney Tubules
1
2021
1
0.190
Why?
Intention to Treat Analysis
1
2021
20
0.190
Why?
Asymptomatic Diseases
3
2016
29
0.190
Why?
Angina, Unstable
4
2014
7
0.190
Why?
Chromosomes, Human, Pair 9
2
2013
7
0.190
Why?
Leukotriene Antagonists
2
2007
12
0.180
Why?
Ontario
1
2020
16
0.180
Why?
HIV Infections
2
2022
694
0.180
Why?
Hip Fractures
2
2016
67
0.180
Why?
Jaw Diseases
2
2011
9
0.180
Why?
Osteonecrosis
2
2011
10
0.180
Why?
Clinical Decision-Making
1
2020
34
0.180
Why?
Respiratory Tract Infections
1
2021
50
0.180
Why?
Cognitive Dysfunction
2
2024
47
0.180
Why?
Appointments and Schedules
1
2020
26
0.180
Why?
Hepatitis A Virus Cellular Receptor 1
2
2017
2
0.180
Why?
Fatty Acid-Binding Proteins
2
2017
2
0.180
Why?
Patient Reported Outcome Measures
1
2020
48
0.180
Why?
Arginine
2
2010
12
0.180
Why?
Long Term Adverse Effects
1
2020
3
0.180
Why?
Europe
4
2015
42
0.180
Why?
Pregnancy
3
2023
1494
0.180
Why?
Anemia, Iron-Deficiency
1
2020
7
0.180
Why?
Physicians
1
2021
137
0.180
Why?
Cigarette Smoking
1
2020
4
0.180
Why?
Diabetic Nephropathies
3
2010
26
0.170
Why?
Vasodilation
2
2011
8
0.170
Why?
Pyrazoles
1
2019
3
0.170
Why?
Executive Function
2
2017
22
0.170
Why?
Population Dynamics
1
2019
6
0.170
Why?
Pyridines
2
2016
9
0.170
Why?
Pyridones
1
2019
8
0.170
Why?
Ischemic Attack, Transient
3
2014
27
0.170
Why?
Gastrointestinal Diseases
2
2018
27
0.170
Why?
Dose-Response Relationship, Drug
3
2017
129
0.170
Why?
Attitude to Health
1
2020
164
0.170
Why?
Cost-Benefit Analysis
3
2016
250
0.170
Why?
International Classification of Diseases
2
2020
85
0.170
Why?
Heart Valve Prosthesis Implantation
2
2016
4
0.170
Why?
Patient Participation
1
2020
133
0.160
Why?
Healthcare Disparities
3
2017
201
0.160
Why?
Health Care Costs
4
2014
228
0.160
Why?
Reoperation
2
2016
30
0.160
Why?
Disease-Free Survival
3
2019
57
0.160
Why?
Withholding Treatment
3
2020
26
0.160
Why?
Smoking Cessation
1
2020
193
0.150
Why?
Genetic Loci
2
2015
55
0.150
Why?
Validation Studies as Topic
1
2017
11
0.150
Why?
Drug Administration Schedule
3
2019
98
0.150
Why?
Cardiologists
1
2017
8
0.150
Why?
Advisory Committees
2
2009
110
0.150
Why?
Estrogen Replacement Therapy
3
2003
99
0.150
Why?
Lipoprotein(a)
1
2017
7
0.150
Why?
Acclimatization
1
2017
1
0.150
Why?
Cyclooxygenase Inhibitors
1
2017
2
0.150
Why?
Ventilation
1
2017
2
0.150
Why?
Patient Admission
1
2018
72
0.150
Why?
Hypoxia
1
2017
8
0.150
Why?
Ibuprofen
1
2017
9
0.150
Why?
beta-Alanine
3
2013
3
0.150
Why?
Cardiac Pacing, Artificial
1
2017
1
0.150
Why?
Tomography, X-Ray Computed
5
2012
205
0.150
Why?
Pacemaker, Artificial
1
2017
2
0.150
Why?
Benzimidazoles
3
2013
6
0.150
Why?
Epigenesis, Genetic
2
2015
25
0.150
Why?
Hypoglycemic Agents
2
2012
268
0.140
Why?
Mice
3
2021
68
0.140
Why?
Ankle Brachial Index
2
2021
8
0.140
Why?
Acetylglucosaminidase
1
2017
1
0.140
Why?
Awareness
1
2017
17
0.140
Why?
Urine Specimen Collection
1
2016
1
0.140
Why?
Urine
1
2016
5
0.140
Why?
Prosthesis Failure
1
2016
3
0.140
Why?
Prosthesis Design
1
2016
4
0.140
Why?
Fee-for-Service Plans
2
2014
24
0.140
Why?
Thiazoles
1
2016
9
0.140
Why?
Drug Labeling
1
2016
14
0.140
Why?
Health Policy
2
2016
122
0.140
Why?
Crotalid Venoms
1
2016
1
0.140
Why?
Atrial Appendage
1
2016
1
0.140
Why?
Computer Simulation
2
2016
81
0.140
Why?
Kidney Neoplasms
2
2014
16
0.140
Why?
Up-Regulation
1
2016
7
0.130
Why?
Health Information Systems
1
2016
3
0.130
Why?
Hyponatremia
1
2016
4
0.130
Why?
Data Mining
1
2016
17
0.130
Why?
Cytokines
1
2016
30
0.130
Why?
Heart Block
1
2016
1
0.130
Why?
Thrombophlebitis
1
2016
2
0.130
Why?
Anesthesia, Conduction
1
1996
1
0.130
Why?
Sick Sinus Syndrome
1
2015
1
0.130
Why?
Anesthesia, General
1
1996
3
0.130
Why?
Hypoalbuminemia
1
2015
1
0.130
Why?
Pulmonary Disease, Chronic Obstructive
1
2018
197
0.130
Why?
Blood Coagulation Tests
1
2015
1
0.130
Why?
Patient Education as Topic
2
2017
211
0.130
Why?
Heart Defects, Congenital
1
2016
37
0.130
Why?
Cord Blood Stem Cell Transplantation
1
2015
1
0.130
Why?
Intermittent Claudication
1
2015
1
0.130
Why?
Hematologic Neoplasms
1
2015
7
0.130
Why?
Ischemia
1
2015
4
0.130
Why?
Endovascular Procedures
1
2015
7
0.130
Why?
Recombinant Proteins
4
2011
14
0.130
Why?
Drug Prescriptions
1
2016
151
0.130
Why?
Community Networks
2
2014
24
0.130
Why?
Hypertriglyceridemia
1
2015
13
0.130
Why?
Body Size
1
2015
31
0.130
Why?
Incidental Findings
3
2013
26
0.130
Why?
Socioeconomic Factors
5
2019
630
0.130
Why?
Phosphates
1
2015
3
0.130
Why?
Brachial Artery
2
2014
6
0.130
Why?
Chemokine CX3CL1
1
2015
1
0.130
Why?
Peer Group
1
2015
48
0.120
Why?
Biological Assay
1
2015
1
0.120
Why?
Healthy Volunteers
1
2015
2
0.120
Why?
Body Fat Distribution
1
2015
5
0.120
Why?
Multicenter Studies as Topic
2
2008
86
0.120
Why?
Adipose Tissue
1
2015
58
0.120
Why?
Retreatment
1
2014
10
0.120
Why?
Quality-Adjusted Life Years
4
2019
38
0.120
Why?
Acute-Phase Proteins
1
2014
2
0.120
Why?
Lipocalins
1
2014
2
0.120
Why?
Ventricular Remodeling
3
2023
6
0.120
Why?
Epidemiologic Research Design
1
2014
18
0.120
Why?
Proto-Oncogene Proteins
1
2014
32
0.120
Why?
Gastrointestinal Hemorrhage
1
2014
20
0.120
Why?
Echocardiography, Stress
1
2014
2
0.120
Why?
Cardiac Catheterization
1
2014
8
0.120
Why?
Body Height
1
2014
62
0.120
Why?
Poisson Distribution
3
2012
88
0.120
Why?
Computer Communication Networks
1
2014
12
0.120
Why?
Myocardial Perfusion Imaging
1
2014
2
0.120
Why?
Regression Analysis
5
2016
297
0.120
Why?
Chemokine CXCL12
1
2013
3
0.110
Why?
Creatine
1
2013
4
0.110
Why?
Voluntary Health Agencies
1
2013
1
0.110
Why?
Serotonin Uptake Inhibitors
1
2014
71
0.110
Why?
Centers for Disease Control and Prevention (U.S.)
1
2013
32
0.110
Why?
Gait
1
2013
6
0.110
Why?
Social Class
3
2023
120
0.110
Why?
DNA Methylation
1
2014
41
0.110
Why?
Postural Balance
1
2013
10
0.110
Why?
Health Priorities
1
2013
26
0.110
Why?
Hospitalists
1
2013
7
0.110
Why?
Gene Frequency
3
2008
43
0.110
Why?
Proteomics
2
2023
8
0.110
Why?
Patient Outcome Assessment
1
2013
28
0.110
Why?
Statistics as Topic
4
2012
64
0.110
Why?
Medicare Part C
1
2013
19
0.110
Why?
Models, Theoretical
1
2013
70
0.110
Why?
Age of Onset
3
2008
79
0.110
Why?
Disease Models, Animal
3
2021
19
0.110
Why?
Digestive System Diseases
1
2013
3
0.110
Why?
Cost of Illness
2
2005
92
0.110
Why?
Chemoprevention
1
2012
12
0.110
Why?
Insulin Resistance
2
2015
133
0.110
Why?
Chest Pain
4
2000
14
0.110
Why?
Hypertensive Retinopathy
1
2012
3
0.110
Why?
Retinal Diseases
1
2012
16
0.110
Why?
Personnel Selection
1
2012
5
0.100
Why?
Marketing of Health Services
1
2012
4
0.100
Why?
Mass Screening
2
2024
661
0.100
Why?
Transforming Growth Factor beta
3
2017
8
0.100
Why?
Tumor Necrosis Factor-alpha
3
2017
27
0.100
Why?
Anti-Bacterial Agents
2
2004
140
0.100
Why?
Nitroglycerin
2
2011
6
0.100
Why?
Magnetic Resonance Angiography
2
2011
8
0.100
Why?
Vasodilator Agents
2
2011
9
0.100
Why?
Medicare Part D
1
2012
15
0.100
Why?
Ambulatory Care
3
2014
244
0.100
Why?
Adamantane
1
2012
3
0.100
Why?
Dipeptides
1
2012
3
0.100
Why?
Community-Based Participatory Research
1
2012
60
0.100
Why?
Mice, Knockout
2
2011
15
0.100
Why?
Patient-Centered Care
1
2014
197
0.100
Why?
Cooperative Behavior
2
2009
91
0.100
Why?
Central Nervous System Stimulants
1
2011
27
0.100
Why?
Societies, Medical
1
2012
74
0.100
Why?
1-Alkyl-2-acetylglycerophosphocholine Esterase
1
2011
5
0.100
Why?
Coronary Circulation
1
2011
4
0.100
Why?
Blood Flow Velocity
2
2009
3
0.100
Why?
Pulse
2
2009
7
0.100
Why?
Tibial Arteries
1
2011
5
0.100
Why?
Dental Care
1
2011
19
0.090
Why?
Infant, Newborn, Diseases
1
2011
34
0.090
Why?
Models, Biological
3
2016
30
0.090
Why?
Attention Deficit Disorder with Hyperactivity
1
2011
64
0.090
Why?
Tryptophan
1
2010
3
0.090
Why?
Kinesin
1
2010
3
0.090
Why?
Health Promotion
1
2013
280
0.090
Why?
Time
1
2010
20
0.090
Why?
Markov Chains
3
2016
23
0.090
Why?
Postmenopause
2
2001
241
0.090
Why?
Psychiatric Status Rating Scales
1
2010
125
0.090
Why?
Interviews as Topic
1
2011
305
0.090
Why?
Pharmacogenetics
2
2008
15
0.090
Why?
Magnetic Resonance Imaging
1
2010
103
0.090
Why?
Vascular Resistance
1
2009
1
0.090
Why?
Aorta
1
2009
5
0.090
Why?
Blood Coagulation
1
2009
2
0.090
Why?
Intensive Care Units
2
2009
104
0.090
Why?
Transplantation, Homologous
1
2009
3
0.090
Why?
Nephrectomy
1
2009
6
0.090
Why?
Confounding Factors (Epidemiology)
3
2012
86
0.090
Why?
Research Support as Topic
1
2009
20
0.090
Why?
Activities of Daily Living
2
2008
85
0.090
Why?
Dialysis
1
2009
1
0.090
Why?
Depression
1
2014
502
0.080
Why?
Anticholesteremic Agents
1
2009
14
0.080
Why?
Evaluation Studies as Topic
1
2009
33
0.080
Why?
Gemfibrozil
1
2009
5
0.080
Why?
Rivaroxaban
2
2023
8
0.080
Why?
Carcinoma, Basal Cell
1
2009
24
0.080
Why?
Bone Density Conservation Agents
1
2009
54
0.080
Why?
Cluster Analysis
2
2024
89
0.080
Why?
Linear Models
3
2017
231
0.080
Why?
Infant, Newborn
1
2011
844
0.080
Why?
Needs Assessment
2
2016
66
0.080
Why?
Glycated Hemoglobin A
4
2016
216
0.080
Why?
Communicable Disease Control
1
2008
18
0.080
Why?
Diabetes Complications
3
2010
114
0.080
Why?
Scavenger Receptors, Class E
1
2008
3
0.080
Why?
Arachidonate 5-Lipoxygenase
1
2008
4
0.080
Why?
Risk Adjustment
1
2008
24
0.080
Why?
Carrier Proteins
1
2008
13
0.080
Why?
Antifibrinolytic Agents
2
2005
3
0.080
Why?
Health Surveys
3
2017
260
0.080
Why?
Mental Health
1
2010
165
0.080
Why?
Colorado
3
2015
163
0.080
Why?
Health Services Research
2
2017
231
0.080
Why?
Program Development
1
2008
69
0.080
Why?
Endpoint Determination
3
2012
10
0.080
Why?
Platelet Membrane Glycoproteins
1
2007
3
0.080
Why?
Matrix Metalloproteinase 2
1
2007
3
0.080
Why?
Myocardial Ischemia
2
2013
24
0.080
Why?
Matrix Metalloproteinase 9
1
2007
4
0.080
Why?
Matrix Metalloproteinases
1
2007
4
0.080
Why?
Fibrin Fibrinogen Degradation Products
1
2007
7
0.080
Why?
Arachidonate 12-Lipoxygenase
1
2007
4
0.080
Why?
Arachidonate 15-Lipoxygenase
1
2007
4
0.080
Why?
Glycemic Index
1
2007
20
0.070
Why?
Arteries
1
2007
8
0.070
Why?
Chemokines
1
2007
8
0.070
Why?
Multiphasic Screening
1
2007
8
0.070
Why?
Anti-HIV Agents
1
2009
155
0.070
Why?
Aluminum
1
2007
14
0.070
Why?
Molecular Epidemiology
2
2008
44
0.070
Why?
Aortic Aneurysm, Abdominal
1
2007
6
0.070
Why?
Epoetin Alfa
1
2007
1
0.070
Why?
Photography
2
2020
9
0.070
Why?
Medical Records
4
2016
100
0.070
Why?
Urinalysis
2
2017
9
0.070
Why?
Abdominal Fat
1
2006
14
0.070
Why?
Leptin
1
2006
29
0.070
Why?
Interleukin 1 Receptor Antagonist Protein
2
2017
12
0.070
Why?
Memory
2
2017
12
0.070
Why?
Drug Utilization
2
2004
127
0.070
Why?
Equipment Design
2
2017
8
0.070
Why?
Neuropsychological Tests
2
2017
38
0.060
Why?
Databases as Topic
4
2009
19
0.060
Why?
Inflammation Mediators
1
2005
7
0.060
Why?
Cardiac Surgical Procedures
1
2005
16
0.060
Why?
Oceanic Ancestry Group
1
2005
33
0.060
Why?
Waist-Hip Ratio
2
2015
23
0.060
Why?
Managed Care Programs
2
2004
325
0.060
Why?
Adipogenesis
2
2015
3
0.060
Why?
Hypothyroidism
1
2005
5
0.060
Why?
Global Health
2
2016
33
0.060
Why?
Medical Record Linkage
2
2016
38
0.060
Why?
Rats
2
2017
29
0.060
Why?
Diagnosis, Computer-Assisted
2
2015
6
0.060
Why?
Macrolides
1
2004
7
0.060
Why?
Drug Interactions
2
2017
20
0.060
Why?
Area Under Curve
2
2019
33
0.060
Why?
Artificial Intelligence
1
2024
17
0.060
Why?
United States Food and Drug Administration
2
2016
34
0.060
Why?
Machine Learning
1
2024
46
0.060
Why?
ROC Curve
2
2019
77
0.060
Why?
Language
2
2016
51
0.060
Why?
Breast Diseases
1
2004
17
0.060
Why?
Enzyme-Linked Immunosorbent Assay
2
2017
17
0.060
Why?
Calcitonin
1
2003
1
0.060
Why?
Breast
1
2004
84
0.060
Why?
Vaccination
1
2008
635
0.060
Why?
Osteoporosis, Postmenopausal
1
2003
42
0.060
Why?
Receptors, Tumor Necrosis Factor
1
2022
4
0.050
Why?
Albumins
1
2022
6
0.050
Why?
RNA
1
2022
12
0.050
Why?
Models, Cardiovascular
2
2013
5
0.050
Why?
Fractures, Bone
1
2003
91
0.050
Why?
Pragmatic Clinical Trials as Topic
1
2023
57
0.050
Why?
Social Determinants of Health
1
2023
37
0.050
Why?
Deoxycholic Acid
1
2022
1
0.050
Why?
Sample Size
2
2012
29
0.050
Why?
Nutritive Value
1
2022
11
0.050
Why?
CD4 Lymphocyte Count
1
2022
178
0.050
Why?
Observer Variation
3
2010
37
0.050
Why?
Brain
1
2022
45
0.050
Why?
Attitude
1
2022
30
0.050
Why?
Feasibility Studies
2
2012
114
0.050
Why?
Patient Freedom of Choice Laws
1
2001
1
0.050
Why?
Pharmacoepidemiology
1
2001
18
0.050
Why?
Energy Metabolism
2
2015
50
0.050
Why?
Pilot Projects
2
2012
218
0.050
Why?
Cresols
1
2021
1
0.050
Why?
Glycine
1
2021
1
0.050
Why?
Indican
1
2021
1
0.050
Why?
Kynurenic Acid
1
2021
1
0.050
Why?
Pyridoxic Acid
1
2021
1
0.050
Why?
Ribonucleosides
1
2021
1
0.050
Why?
Sulfuric Acid Esters
1
2021
1
0.050
Why?
Organic Anion Transporters
1
2021
1
0.050
Why?
Xanthines
1
2021
6
0.050
Why?
Chromatography, Liquid
1
2021
6
0.050
Why?
Tandem Mass Spectrometry
1
2021
6
0.050
Why?
Health Services Misuse
1
2001
14
0.050
Why?
Health Services for the Aged
1
2001
14
0.050
Why?
Africa
2
2011
6
0.050
Why?
Galectins
1
2020
1
0.050
Why?
Blood Proteins
1
2020
3
0.050
Why?
Heart Valves
1
2000
4
0.050
Why?
Smoking
3
2010
483
0.040
Why?
Transferrins
1
2020
4
0.040
Why?
Transferrin
1
2020
5
0.040
Why?
Ferritins
1
2020
9
0.040
Why?
Contraindications
1
1999
14
0.040
Why?
Internal Medicine
1
2000
20
0.040
Why?
Referral and Consultation
1
2001
167
0.040
Why?
Hematologic Tests
1
2019
3
0.040
Why?
Family Practice
1
2000
44
0.040
Why?
Datasets as Topic
1
2019
17
0.040
Why?
Heart Arrest
1
2019
34
0.040
Why?
Cardiology Service, Hospital
1
1999
2
0.040
Why?
Death
1
2019
10
0.040
Why?
Diagnosis-Related Groups
1
1999
24
0.040
Why?
Diet
1
2022
365
0.040
Why?
Reference Values
2
2011
91
0.040
Why?
Asia
2
2011
15
0.040
Why?
Residence Characteristics
1
2020
248
0.040
Why?
Glial Fibrillary Acidic Protein
1
2017
1
0.040
Why?
Respiratory Center
1
2017
1
0.040
Why?
Solitary Nucleus
1
2017
1
0.040
Why?
Neuroglia
1
2017
3
0.040
Why?
Microfilament Proteins
1
2017
3
0.040
Why?
Rats, Sprague-Dawley
1
2017
8
0.040
Why?
Calcium-Binding Proteins
1
2017
3
0.040
Why?
Cardiac Resynchronization Therapy Devices
1
2017
2
0.040
Why?
Drug Substitution
1
2017
10
0.040
Why?
Interleukin-1beta
1
2017
2
0.040
Why?
Pulse Wave Analysis
1
2017
3
0.040
Why?
Comprehension
1
2017
17
0.040
Why?
Hypercholesterolemia
2
2010
32
0.040
Why?
Interleukin-18
1
2016
1
0.040
Why?
Organ Size
1
2016
15
0.040
Why?
Diastole
1
2016
5
0.030
Why?
Myocardial Reperfusion
2
2007
2
0.030
Why?
Accidental Falls
1
2016
38
0.030
Why?
Heparin, Low-Molecular-Weight
2
2008
10
0.030
Why?
Iothalamic Acid
1
2016
2
0.030
Why?
Interleukin-1
1
2016
2
0.030
Why?
Serum Albumin
1
2016
4
0.030
Why?
Septal Occluder Device
1
2016
1
0.030
Why?
Decision Trees
1
2016
18
0.030
Why?
Data Curation
1
2016
1
0.030
Why?
Goals
1
2016
30
0.030
Why?
Sweden
1
2016
19
0.030
Why?
Orientation
1
2016
1
0.030
Why?
Trail Making Test
1
2016
2
0.030
Why?
Psychomotor Performance
1
2016
4
0.030
Why?
Monte Carlo Method
1
2016
15
0.030
Why?
Intraoperative Complications
1
1996
5
0.030
Why?
Attention
1
2016
10
0.030
Why?
Caregivers
1
2017
127
0.030
Why?
Cuba
1
2015
1
0.030
Why?
Dominican Republic
1
2015
1
0.030
Why?
Medical Informatics
1
2016
38
0.030
Why?
Puerto Rico
1
2015
5
0.030
Why?
South America
1
2015
4
0.030
Why?
Diagnosis
1
1995
5
0.030
Why?
Central America
1
2015
4
0.030
Why?
Cell Line
2
2012
9
0.030
Why?
Allografts
1
2015
1
0.030
Why?
Chromosome Mapping
1
2015
17
0.030
Why?
Platelet Count
1
2015
9
0.030
Why?
Mexico
1
2015
19
0.030
Why?
Leukocyte Count
1
2015
21
0.030
Why?
Amputation
1
2015
11
0.030
Why?
Surgical Wound Infection
1
2015
7
0.030
Why?
Diabetic Angiopathies
1
2015
35
0.030
Why?
Nutrition Surveys
1
2015
61
0.030
Why?
Myocardial Contraction
1
2015
1
0.030
Why?
Retinal Artery
1
2015
2
0.030
Why?
Retinal Vein
1
2015
2
0.030
Why?
Angiography
1
2015
12
0.030
Why?
Frail Elderly
1
2015
9
0.030
Why?
Glutamic Acid
1
2015
2
0.030
Why?
Synapses
1
2015
2
0.030
Why?
Adipocytes
1
2015
4
0.030
Why?
Transcription, Genetic
1
2015
7
0.030
Why?
Neovascularization, Physiologic
1
2015
3
0.030
Why?
Psychotic Disorders
1
2015
44
0.030
Why?
Stress Disorders, Post-Traumatic
1
2015
58
0.030
Why?
Genome, Human
1
2015
32
0.030
Why?
Clinical Competence
1
1995
99
0.030
Why?
Anxiety Disorders
1
2015
91
0.030
Why?
Peripheral Vascular Diseases
1
2014
4
0.030
Why?
Genetics, Population
1
2014
8
0.030
Why?
Oligonucleotide Array Sequence Analysis
1
2014
23
0.030
Why?
Radial Artery
1
2014
2
0.030
Why?
Femoral Artery
1
2014
4
0.030
Why?
San Francisco
2
2008
64
0.030
Why?
Epithelial-Mesenchymal Transition
1
2014
1
0.030
Why?
Metabolic Clearance Rate
1
2013
4
0.030
Why?
Information Dissemination
1
2014
51
0.030
Why?
Muscle Weakness
1
2013
3
0.030
Why?
Drug Synergism
1
2013
3
0.030
Why?
Capitation Fee
1
2013
12
0.030
Why?
Fatigue
1
2013
34
0.030
Why?
Depressive Disorder
1
2015
222
0.030
Why?
Geography
1
2013
39
0.030
Why?
Reimbursement, Incentive
1
2013
27
0.030
Why?
Cerebrovascular Disorders
1
2013
34
0.030
Why?
Peritoneal Dialysis
1
2013
7
0.030
Why?
History, Ancient
1
2013
2
0.030
Why?
Ultrasonography
1
2013
35
0.030
Why?
Gene Regulatory Networks
1
2012
9
0.030
Why?
Protein Precursors
1
2012
4
0.030
Why?
Multilingualism
1
2012
7
0.030
Why?
Chicago
1
2012
26
0.030
Why?
Double-Blind Method
1
2012
155
0.030
Why?
Amiodarone
1
2012
2
0.030
Why?
Postoperative Period
1
2012
16
0.030
Why?
Calcium Channel Blockers
1
2012
14
0.030
Why?
Informed Consent
1
2012
19
0.030
Why?
Drug Approval
1
2012
12
0.030
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2012
5
0.020
Why?
Glucuronidase
1
2011
1
0.020
Why?
Fibroblast Growth Factor 2
1
2011
1
0.020
Why?
Receptors, Fibroblast Growth Factor
1
2011
1
0.020
Why?
Myocytes, Cardiac
1
2011
1
0.020
Why?
Philippines
1
2011
22
0.020
Why?
Mice, Inbred C57BL
1
2011
17
0.020
Why?
Wounds and Injuries
1
2012
47
0.020
Why?
Drug Utilization Review
2
2003
25
0.020
Why?
Signal Transduction
1
2011
30
0.020
Why?
Alcoholism
1
2015
347
0.020
Why?
Decision Making
1
2013
183
0.020
Why?
Nitric Oxide Donors
1
2011
3
0.020
Why?
Ultrasonography, Doppler
1
2011
5
0.020
Why?
Critical Illness
1
2012
50
0.020
Why?
Critical Care
1
2012
71
0.020
Why?
Delayed Diagnosis
1
2011
19
0.020
Why?
Product Surveillance, Postmarketing
1
2012
95
0.020
Why?
Weight Loss
1
2013
303
0.020
Why?
Proviruses
1
1990
1
0.020
Why?
Internationality
1
2010
14
0.020
Why?
Virus Replication
1
1990
12
0.020
Why?
Health Planning Guidelines
1
2010
8
0.020
Why?
United States Department of Veterans Affairs
1
2011
127
0.020
Why?
Insurance Coverage
1
2011
106
0.020
Why?
Parathyroid Hormone
1
2010
9
0.020
Why?
HIV-1
1
1990
70
0.020
Why?
Medication Therapy Management
1
2010
6
0.020
Why?
Chemotherapy, Adjuvant
1
2010
70
0.020
Why?
Pulsatile Flow
1
2009
1
0.020
Why?
Prescriptions
1
2010
27
0.020
Why?
Principal Component Analysis
1
2009
23
0.020
Why?
Statistics, Nonparametric
1
2010
50
0.020
Why?
Emigration and Immigration
1
2009
15
0.020
Why?
Etidronic Acid
1
2009
3
0.020
Why?
Tooth Extraction
1
2009
5
0.020
Why?
Self Report
1
2011
251
0.020
Why?
Alendronate
1
2009
15
0.020
Why?
Psychometrics
1
2010
121
0.020
Why?
Educational Status
1
2009
200
0.020
Why?
Emigrants and Immigrants
1
2009
27
0.020
Why?
Injections, Subcutaneous
1
2008
4
0.020
Why?
Injections, Intravenous
1
2008
10
0.020
Why?
5-Lipoxygenase-Activating Proteins
1
2008
4
0.020
Why?
Promoter Regions, Genetic
1
2008
15
0.020
Why?
Linkage Disequilibrium
1
2008
30
0.020
Why?
Image Interpretation, Computer-Assisted
1
2008
12
0.020
Why?
Public Health
1
2009
80
0.020
Why?
Alleles
1
2008
84
0.020
Why?
Plasminogen Activator Inhibitor 1
1
2007
3
0.020
Why?
Diagnosis, Differential
2
2000
60
0.020
Why?
Cell Line, Tumor
1
2007
8
0.020
Why?
Disease Susceptibility
1
2007
37
0.020
Why?
Mutagenesis
1
2007
5
0.020
Why?
Manometry
1
2007
1
0.020
Why?
Tissue Plasminogen Activator
1
2007
23
0.020
Why?
Sulfonylurea Compounds
1
2007
24
0.020
Why?
Protein Array Analysis
1
2007
5
0.020
Why?
Thiazolidinediones
1
2007
52
0.020
Why?
Metformin
1
2007
57
0.020
Why?
Early Diagnosis
1
2007
38
0.020
Why?
Adrenal Cortex Hormones
1
2007
68
0.020
Why?
Leisure Activities
1
2006
31
0.020
Why?
Pacific Islands
1
2005
5
0.020
Why?
Phosphorus
1
2005
6
0.020
Why?
Drug Resistance
1
2005
30
0.020
Why?
Heparin
1
2004
9
0.020
Why?
Lung Neoplasms
1
2008
255
0.010
Why?
Radiography
1
2004
39
0.010
Why?
Wrist Injuries
1
2003
1
0.010
Why?
Spinal Fractures
1
2003
12
0.010
Why?
Women's Health
1
2004
200
0.010
Why?
Vitamin K 1
1
2001
1
0.010
Why?
Half-Life
1
2001
5
0.010
Why?
Economics, Pharmaceutical
1
2001
2
0.010
Why?
Sampling Studies
1
2001
51
0.010
Why?
Syndrome
1
2001
28
0.010
Why?
Hospitals, Community
1
2001
23
0.010
Why?
Drug Therapy
1
2001
18
0.010
Why?
Health Education
1
2001
111
0.010
Why?
Controlled Clinical Trials as Topic
1
2000
4
0.010
Why?
Troponin
1
2000
9
0.010
Why?
Drug-Related Side Effects and Adverse Reactions
1
2001
107
0.010
Why?
Meta-Analysis as Topic
1
2000
32
0.010
Why?
Patient Satisfaction
1
2001
211
0.010
Why?
Medicare Part A
1
1999
3
0.010
Why?
Medical Audit
1
1999
38
0.010
Why?
Hospitals, University
1
1999
16
0.010
Why?
Probability
1
1999
79
0.010
Why?
Hospitals, General
1
1995
4
0.010
Why?
Schools, Medical
1
1995
16
0.010
Why?
Massachusetts
1
1995
93
0.010
Why?
Globins
1
1990
1
0.010
Why?
Lymphocytes
1
1990
1
0.010
Why?
Oligonucleotide Probes
1
1990
3
0.010
Why?
Cloning, Molecular
1
1990
3
0.010
Why?
Kinetics
1
1990
12
0.010
Why?
Base Sequence
1
1990
19
0.010
Why?
Cells, Cultured
1
1990
12
0.010
Why?
Molecular Sequence Data
1
1990
17
0.010
Why?
DNA, Viral
1
1990
17
0.010
Why?
Lymphocyte Activation
1
1990
7
0.010
Why?
Leukocytes
1
1990
10
0.010
Why?
Polymerase Chain Reaction
1
1990
49
0.010
Why?
Concepts (919)
Explore
_
Co-Authors (55)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_
-->

© 2025 Kaiser Permanente